Insider Transactions in Q3 2022 at Opiant Pharmaceuticals, Inc. (OPNT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Matthew R. Ruth Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,084
-3.5%
|
$10,840
$10.62 P/Share
|
|
Jul 14
2022
|
Phil Skolnick Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
627
-2.56%
|
$6,897
$11.85 P/Share
|
|
Jul 14
2022
|
David D O'Toole Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
779
-2.07%
|
$8,569
$11.1 P/Share
|
|
Jul 14
2022
|
Brian Gorman |
SELL
Open market or private sale
|
Direct |
691
-2.01%
|
$7,601
$11.16 P/Share
|
|
Jul 14
2022
|
Roger Crystal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,246
-2.64%
|
$24,706
$11.11 P/Share
|